Closed transaction
Deal details
Medix Biochemica, a global leader in critical IVD raw materials, has acquired 100 percent of the shares of Diaclone from Biotech Investissement Group. As a result of the acquisition, Medix Biochemica broadens its portfolio of critical raw materials for the in vitro diagnostics (“IVD”) industry, complements its scientific expertise and strengthens its local presence in Western Europe. Diaclone will become an important part of the Immunodiagnostic Reagents Business Unit within Medix Biochemica’s group structure, and its high-quality operations will continue in Besançon, France.
More deals in Healthcare
NUTRIBRAIN was sold to LABORATORIOS RUBIÓ.
- Adviser
- INEO Corporate
- Where
- Spain
- Year
- 2026
PharmaX Solutions was sold to BioPhorum.
- Adviser
- Hoffmann & Partner
- Where
- Switzerland
- Year
- 2026
Nostos Genomics was sold to Limbus Medical Technologies (varvis®).
- Adviser
- Hoffmann & Partner
- Where
- Switzerland
- Year
- 2025
3iM Healthcare AB acquired Avia Pharma.
- Adviser
- Evli Corporate Finance AB
- Where
- Finland
- Year
- 2025
More deals in Europe
houzy and myky join forces under Swiss Digital Home AG.
- Adviser
- Hoffmann & Partner
- Where
- Switzerland
- Year
- 2026
Fibreactive sold to discoverIE Group plc.
- Adviser
- FRP Corporate Finance
- Where
- United Kingdom
- Year
- 2026
The Vella Group acquired RGM Vehicle Body Repairs.
- Adviser
- FRP Corporate Finance
- Where
- United Kingdom
- Year
- 2026
Elite Vehicle Supplies received investment from Vehicle Accessories Solutions Ltd T/A Motormax.
- Adviser
- FRP Corporate Finance
- Where
- United Kingdom
- Year
- 2026
Membership
Gain worldwide reach with CapFive M&A professionals
The professionals of CapFive have been carefully selected on the basis of reputation, relationships, proven track record and knowledge of local markets.
Become a member